Abstracts tagged "Arthritis and infection"

Abstract Number: 1216 • 2018 ACR/ARHP Annual Meeting
To Study the Frequency of Persistent Arthritis, in Patients with Chikungunya Fever, in a Tertiary Health Care Center
Hamza Alam¹, Tahira Perveen¹, Lubna Nazir¹ and Iffat Khanum², ¹Rheumatology, Liaquat National Hospital, Karachi, Pakistan, ²Infectious Diseases, Liaquat National Hospital, Karachi, Pakistan
Background/Purpose: Chikungunya virus is an alphavirus, belonging to the Togaviridae family. It is transmitted by several species of mosquitoes, with Aedes species being main culprit.…
Abstract Number: 1218 • 2018 ACR/ARHP Annual Meeting
Synovial Fluid Culture: Comparison of Two Culture Methods
Ayman Natsheh¹, Daniel Cohen², Elyahu Ben Chetrit³, Gideon Nesher⁴ and Gabriel S Breuer¹, ¹Rheumatology, Shaare Zedek Medical Center, Jerusalem, Israel, ²Orthopedics, Shaare Zedek Medical Center, Jerusalem, Israel, ³Incectious Diseases, Shaare Zedek Medical Center, Jerusalem, Israel, ⁴Medicine, Shaare Zedek Medical Center, Jerusalem, Israel
Background/Purpose: Septic arthritis (SA) is one of the emergencies in rheumatology. This pathology is more common due to the increased usage of artificial joints. Culture…
Abstract Number: 1219 • 2018 ACR/ARHP Annual Meeting
Antibiotic Resistance Trends Among Bacteria Causing Septic Arthritis at One Medical Center between 2002-2016
Gabriel S Breuer¹, Amit Zamir², Gideon Nesher² and Elyahu Ben Chetrit², ¹Rheumatology, Shaare Zedek Medical Center, Jerusalem, Israel, ²Medicine, Hebrew University School of Medicine, Jerusalem, Israel
Background/Purpose: Septic arthritis (SA) is caused mainly by Staphylococcus aureus(S. aureus). Methicillin-resistant S. aureus (MRSA) SA is increasing and accounts for 25-50% of all S.…
Abstract Number: 1320 • 2016 ACR/ARHP Annual Meeting
Chikungunya Fever Outbreak in Brazil: Preliminary Assessment in a Cohort of Patients with Rheumatological Manifestations
Claudia Marques¹, Nara Cavalcanti², Mariana Luna³, Paula Toche², Carolina Andrade², Andrea Dantas², Aline Ranzolin², Laurindo Rocha Jr⁴, Eutília Freire⁵, Pablo Cardoso⁶, Kamila Vilar⁷, Michelly Pereira⁸, Moacyr Rêgo⁸, Maira Pitta⁶ and Angela Duarte⁹, ¹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ²Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, ³Universidade Federal de Pernambuco, Recife, Brazil, ⁴Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁵Universidade Federal da Paraíba, João Pessoa, Brazil, ⁶Departamento de Bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁷Departamento de bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁸Bioquimica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, PE, Brazil
Background/Purpose: Chikungunya virus (CHIKV) emerged in Brazil in September 2014. Since then the infection reached epidemic proportions in the country, paticularly in the Northeast region…
Abstract Number: 1344 • 2015 ACR/ARHP Annual Meeting
The Positive Synovial Fluid Culture: Septic Arthritis or Contamination?
Clara Zhu¹, Mary Louise Fowler², Sarah B. Lieber³, Andrew Moore⁴, Robert H. Shmerling⁵ and Ziv Paz³, ¹Medical School, Boston University School of Medicine, Boston, MA, ²School of Medicine, Boston University School of Medicine, Boston, MA, ³Beth Israel Deaconess Medical Center, Boston, MA, ⁴Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, ⁵Medicine, Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: Isolation of bacteria from synovial fluid (SF) is the gold standard for the diagnosis of septic arthritis (SA). However, false positive culture results (contamination)…
Abstract Number: 1348 • 2015 ACR/ARHP Annual Meeting
Clinical Characteristics and Outcomes of Patients with Septic Arthritis Treated without Surgery
Sarah B. Lieber¹, Andrew Moore², Clara Zhu³, Robert H. Shmerling⁴, Mary Louise Fowler⁵ and Ziv Paz¹, ¹Beth Israel Deaconess Medical Center, Boston, MA, ²Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, ³Medical School, Boston University School of Medicine, Boston, MA, ⁴Medicine, Beth Israel Deaconess Medical Center, Boston, MA, ⁵School of Medicine, Boston University School of Medicine, Boston, MA
Background/Purpose: Septic arthritis (SA) is typically managed with antibiotics and surgery, though nonsurgical management may be appropriate in certain circumstances. Little is known about how…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].